Hengrui Pharmaceutical announced that Zhu Guo was the new senior vice president of the company. Zhu Guoxin has more than 30 years of global cross-functional drug discovery leadership experience, covering all stages from target hypothesis to early clinical testing, covering various disease fields such as diabetes/obesity and its complications, immunology, neurological diseases, pain, and tumors. Prior to joining the company, Zhu Guoxin served as vice president at Eli Lilly's New Drug R&D Center, led several discovery research and early development projects, chaired the Small Molecule Strategy Group, and oversaw the research and delivery of more than 100 small molecule clinical drug candidates.

Hengrui Pharmaceutical announced that Zhu Guo was the new senior vice president of the company. Zhu Guoxin has more than 30 years of global cross-functional drug discovery leadership experience, covering all stages from target hypothesis to early clinical testing, covering various disease fields such as diabetes/obesity and its complications, immunology, neurological diseases, pain, and tumors. Prior to joining the company, Zhu Guoxin served as vice president at Eli Lilly's New Drug R&D Center, led several discovery research and early development projects, chaired the Small Molecule Strategy Group, and oversaw the research and delivery of more than 100 small molecule clinical drug candidates.